Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma

Fig. 5

Imaging of patient B before and after treatment. A–C MRI findings at the time of recurrence. The red arrows indicate the lesion. D–F Results of MRI re-examination after 12 weeks of combined medication. The red arrow indicates the original lesion site. G–I CT scan at 6 months after liver transplantation. The green arrow indicates the portal vein, the yellow arrow indicates the bile duct, and the blue arrow indicates the inferior vena cava

Back to article page